UnknownNCT04055831

Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease

Studying Gaucher disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lysosomal and Rare Disorders Research and Treatment Center, Inc.
Principal Investigator
Ozlem Goker-Alpan, MD
Lysosomal and Rare Disorders Research and Treatment Center
Enrollment
40 enrolled
Eligibility
16-90 years · All sexes
Timeline
2019 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04055831 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials